Connexin expression in Huntington's diseased human brain

被引:90
|
作者
Vis, JC
Nicholson, LFB
Faull, RLM
Evans, WH
Severs, NJ
Green, CR
机构
[1] Univ Auckland, Sch Med, Dept Anat Radiol, Auckland, New Zealand
[2] Univ Nijmegen Hosp, Dept Neurol, NL-6500 HB Nijmegen, Netherlands
[3] Cardiff Univ, Dept Med Biochem, Cardiff CF4 4XN, S Glam, Wales
[4] Univ London Imperial Coll Sci Technol & Med, Dept Cardiac Med, London, England
关键词
gap junctions; Huntington's disease; astrocytes; connexins; GFAP;
D O I
10.1006/cbir.1998.0388
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
In Huntington's diseased human brain, it is in the caudate nucleus (CN) and globus pallidus (GP) of the basal ganglia where nerve cell death is seen most dramatically. The distribution of five gap junction proteins (connexins 26, 32, 40, 43 and 50) has been examined in these areas in normal and Huntington's diseased human brain using immunohistochemical techniques. There was no Cx50 expression observed and Cx40 was localized in the endothelial cells of blood vessels, with the Huntington's diseased brains having more numerous and smaller blood vessels than normal tissue. Cx26 and Cx32 revealed a similar distribution pattern to each other in both normal and diseased brains with little labelling in the CN but clear labelling in the GP. Cx43, expressed by astrocytes, was the most abundant connexin type of those studied. In both normal and diseased brains Cx43 in the GP was homogeneously distributed in the neuropil. In the CN, however, Cx43 density was both increased with Huntington's disease and became located in patches. Glial fibrillary acidic protein(GFAP) staining of astrocytes was also highly increased in the CN compared with normal brains. These labelling patterns indicate a reactive astrocytosis around degenerating neurons with an increased expression of astrocytic gap junctions. The enhanced coupling state between astrocytes, assuming the junctions are functional, could provide an increased spatial buffering capacity by the astrocytes in an attempt to maintain a proper environment for the neurons, helping promote neuronal survival in this neurodegenerative disorder. (C) 1998 Academic Press.
引用
收藏
页码:837 / 847
页数:11
相关论文
共 50 条
  • [41] Integrating behaviour and brain gene expression in Huntington's disease transgenic mouse models
    Hughes, GP
    Brooks, SP
    Hodges, AH
    Holmans, P
    Thomas, JM
    Goldstein, D
    Dunnett, SB
    Jones, L
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2005, 76
  • [42] Expression of connexin 26 and connexin 43 is reduced in Hirschsprung's disease
    Coyle, David
    Doyle, Brian
    Murphy, Justin M.
    O'Donnell, Anne Marie
    Gillick, John
    Puri, Prem
    JOURNAL OF SURGICAL RESEARCH, 2016, 206 (01) : 242 - 251
  • [43] Protein expression in the striatum and cortex regions of the brain for a mouse model of Huntington's disease
    Liu, Xiaoyun
    Miller, Benjamin R.
    Rebec, George V.
    Clemmer, David E.
    JOURNAL OF PROTEOME RESEARCH, 2007, 6 (08) : 3134 - 3142
  • [44] Abnormal connexin expression in human chronic wounds
    Sutcliffe, J. E. S.
    Chin, K. Y.
    Thrasivoulou, C.
    Serena, T. E.
    O'Neil, S.
    Hu, R.
    White, A. M.
    Madden, L.
    Richards, T.
    Phillips, A. R. J.
    Becker, D. L.
    BRITISH JOURNAL OF DERMATOLOGY, 2015, 173 (05) : 1205 - 1215
  • [45] Huntington's disease - Exploiting expression
    Bates, GP
    NATURE, 2001, 413 (6857) : 691 - +
  • [46] Brain energy metabolism in Huntington's disease
    Wieler, M
    Hanstock, C
    Martin, W
    MOVEMENT DISORDERS, 2004, 19 : S372 - S372
  • [47] Deep brain stimulation in Huntington's disease
    Bonomo, Roberta
    Elia, Antonio
    Bonomo, Giulio
    Romito, Luigi
    Mariotti, Caterina
    Devigili, Grazia
    Cilia, Roberto
    Giossi, Riccardo
    Eleopra, Roberto
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 344 - 345
  • [48] Brain Microbiota in Huntington's Disease Patients
    Alonso, Ruth
    Pisa, Diana
    Carrasco, Luis
    FRONTIERS IN MICROBIOLOGY, 2019, 10
  • [49] Brain structure in preclinical Huntington's disease
    Paulsen, JS
    Magnotta, VA
    Mikos, AE
    Paulson, HL
    Penziner, E
    Andreasen, NC
    Nopoulos, PC
    BIOLOGICAL PSYCHIATRY, 2006, 59 (01) : 57 - 63
  • [50] Deep brain stimulation in Huntington's disease
    Bonelli, RM
    Gruber, A
    MOVEMENT DISORDERS, 2002, 17 (02) : 429 - 430